M
10b5-1 Plan
$ Value
$0
Shares
5,000
Price
$0
Filed
Dec 8
Insider
Name
Accardi Mario Alberto
Title
President, Orexin Program
CIK
0002074392
Roles
Officer
Transaction Details
Transaction Date
2025-12-08
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,250
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025. | 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments with the first installment vesting on March 1, 2022.
Filing Info
Accardi Mario Alberto's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-02 | CNTA | A | $0 |
| 2026-02-02 | CNTA | A | $0 |
| 2026-02-01 | CNTA | F | $72K |
| 2025-12-09 | CNTA | ▼ | $213K |
| 2025-12-09 | CNTA | ▼ | $75K |
| 2025-12-08 | CNTA | M | $48K |
| 2025-12-08 | CNTA | ▼ | $300K |
| 2025-12-08 | CNTA | M | $0 |
| 2025-11-01 | CNTA | F | $15K |
| 2025-10-27 | CNTA | M | $40K |
Other Insiders at CNTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Weinhoff Gregory M
Chief Business Officer
|
— | $2.6M | 2026-03-26 |
|
Crowley John J
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Kanes Stephen
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Anderson Karen M.
Chief People Officer
|
— | $6.5M | 2026-03-26 |
|
HUSSAIN IQBAL J
Chief Legal Officer
|
— | $1.0M | 2026-02-02 |
|
Bush Tia L
Chief Technology & Quality Ofc
|
— | — | 2026-02-02 |
|
Deferiere Raphael
Chief Accounting Officer
|
— | — | 2026-02-02 |
|
Accardi Mario Alberto
Chief Executive Officer
|
— | — | 2026-02-02 |